Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-029437

Chief Financial Officer bought 1,000 shares at $15.00 ($15,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silver Brian M. Chief Financial Officer 2021-07-20 Purchase +1,000 $15.00 $15,000 1,000 D
Open-market purchases · 1,000 sh · avg $15.00 · $15,000
Loading xslF345X03/doc4.xml…